Quarter Period Consolidated Statement Of Comprehensive Income

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7297738

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
6,555,000,000 JPY
6,953,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-16,000,000 JPY
50,000,000 JPY
Foreign currency translation adjustment
-1,883,000,000 JPY
4,447,000,000 JPY
Other comprehensive income
-1,900,000,000 JPY
4,498,000,000 JPY
Comprehensive income
4,654,000,000 JPY
11,451,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,654,000,000 JPY
11,451,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.